---

Teriparatide in fracture healing: Case series and review of literature

Full Text PDF

---

Case Series

Author Details : Amit B Jain, S S Jha*, Nilanj Dave, Alok Chaturvedi, Sandesh Warudkar

Volume : 7, Issue : 2, Year : 2021

Article Page : 93-100

https://doi.org/10.18231/j.ijor.2021.021

Suggest article by email

Get Permission

Abstract

Teriparatide (TPTD) (recombinant Parathyroid Hormone 1-34) is one of the pioneer osteo-anabolic agents approved for management of osteoporosis. Being an anabolic agent, it increases bone mineral density by inducing formation of new bone by the action on osteoblasts. As new bone formation is an important aspect of fracture healing as well, Teriparatide has long been a product of interest with respect to its effect on the process of fracture healing. Though fracture healing is not an approved indication for Teriparatide, there is quite a substantial amount of published data related to its effectiveness in fracture healing. With an intent to better understand the role of teriparatide in fracture, we share few case reports of successful fracture healing after giving Teriparatide and also review the published evidences of union taking place in difficult delayed union and non-union cases secondary to mechanical instability, inadequate fixation support or other reasons. This article thus, intended to summarize the accumulating preclinical and clinical evidence for role of TPTD in accelerating fracture healing in various conditions like conservative management of fractures, vertebral fractures, non-unions, delayed unions and atypical femoral fractures.
 

Keywords: Teriparatide, Fracture healing, rPTH, Nonunion, Delayed union

How to cite : Jain A B, Jha S S, Dave N, Chaturvedi A, Warudkar S, Teriparatide in fracture healing: Case series and review of literature. IP Int J Orthop Rheumatol 2021;7(2):93-100

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.